← Peptide guides
Peptide guides

CJC-1295/Ipamorelin 10 + 10 mg in Bali: What the Label Tells You

A linked catalog transcription of the CJC-1295/Ipamorelin composition: 10 mg of each peptide, 20 mg combined content and separate formulation fields. Product and ordering context for Bali, Indonesia.

AI concept: a closed pen with CJC-1295 10 mg and Ipamorelin 10 mg cards, totalling 20 mg per pen.
AI-generated editorial illustration
In this article
  1. A worked transcription
  2. Which details remain separate?
  3. What to carry into a comparison
  4. Compare the format offered in Bali
  5. Product formats to compare in Bali
  6. Confirm your Bali order

The CJC-1295/Ipamorelin “10 + 10 mg” description means 10 mg of CJC-1295 and 10 mg of Ipamorelin per pen. Together they give the 20 mg total in the catalog product name. The two ingredient names are essential: the entire 20 mg is not CJC-1295 alone. A CJC-1295 + Ipamorelin comparison in Bali, Indonesia, starts with the complete product: ingredients, total contents, device and what comes in the pack.

The CJC-1295/Ipamorelin product entry is the source for this transcription. Its catalog pack heading reads “CJC1295 & IPAMORELIN 20”; the composition specifies 10 mg of each peptide in the pen. The catalog variant records this as “10 mg + 10 mg / pen.”

A worked transcription

A concise record of this offer is:

CJC-1295 10 mg + Ipamorelin 10 mg — one pen — 20 mg combined declared peptide content.

The ingredient split is useful when a shortened heading says only “CJC/IPA 20.” CJC and IPA are shorthand in that context; the expanded composition tells you which two substances the shorthand represents.

Equal masses mean an equal mass ratio in the declared composition. They do not imply equal biological potency or equal contributions to a measured hormone response.

Which details remain separate?

The catalog pack transcription places excipients on a separate line. Those ingredients describe the formulation around the peptides. The transcribed label also carries a single-patient-use statement, which concerns who the device is intended for rather than how its peptide content is divided.

The amount statement “10 mg + 10 mg” does not itself specify DAC status. That is a distinct identity question for CJC-1295, not something the 10 mg number resolves. The human CJC-1295 publication describes a defined long-acting molecule; an article citing it should match that identity explicitly. CJC-1295 human study.

Ipamorelin also has its own pharmacology literature. A study of that individual ingredient is different from a study of this finished two-component pen. Ipamorelin human study.

What to carry into a comparison

Keep the full pair and separate amounts when comparing another listing. A 20 mg single-ingredient product and a 10 + 10 mg blend can share the same total while containing different substances.

For this catalog offer, the concrete answer is the two-part composition. Concentration, device output and a personal treatment amount are separate fields; the total-content heading alone does not provide them.

Compare the format offered in Bali

Separate the ingredient, total labelled contents, device and number of units in the pack. A larger number on the box does not identify a dose or a personal treatment duration. Check whether the listing supplies a complete pen, a cartridge or another presentation, and whether accessories are included. Keep those details beside the product name when comparing offers.

Product formats to compare in Bali

Compare the following catalogue entries with the product or route discussed above. The stated amount is the total labelled pack content, not a dose or a promise of how long it will last.

Catalogue product Labelled contents What to distinguish
CJC-1295 + Ipamorelin 10 mg + 10 mg / pen Two ingredients; confirm the exact CJC component and DAC information.

Confirm your Bali order

For Canggu, Berawa, Pererenan, Umalas, Seminyak or Uluwatu, send the exact product, quantity and destination. Ask the team to confirm the delivery arrangements for that address before relying on a proposed time.

View all pen formats · Ask about the exact product on WhatsApp

Sources

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
  2. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
  3. Catalog product entry: cjc-ipa

Source and editorial checks completed. How these articles are prepared.

Related reading